Sopharma AD is a diversified pharmaceutical company based in Bulgaria, engaging in the development, production, and distribution of pharmaceutical products. Its primary function is to manufacture a wide range of healthcare solutions, including over-the-counter (OTC) medicines, prescription drugs, and nutritional supplements. Sopharma AD operates across various therapeutic areas such as cardiology, neurology, gastroenterology, and dermatology, significantly impacting these sectors by providing essential medications.

The company plays a vital role in the healthcare market, not only within Bulgaria but also across Eastern Europe and other regions, due to its integrated approach to both manufacturing and distribution. Known for its innovative research capabilities, Sopharma AD emphasizes product development aligned with international quality standards, ensuring its offerings meet the dynamic needs of the medical community and patients.

As a prominent entity in the pharmaceutical industry, Sopharma AD contributes to the accessibility and advancement of healthcare solutions, leveraging its extensive distribution network and strategic partnerships. This enhances its market significance and reinforces its commitment to improving health outcomes on a global scale.